Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Robert Z Orlowski
Flavopiridol Enhances ABT-199 Sensitivity in Unfavourable-Risk Multiple Myeloma Cells in Vitro and in Vivo
British Journal of Cancer
Cancer Research
Oncology
Clinical Implications of Cytogenetic Heterogeneity in Multiple Myeloma Patients With TP53 Deletion
Modern Pathology
Forensic Medicine
Pathology
Related publications
A Phase I Trial of Flavopiridol in Relapsed Multiple Myeloma
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients
Blood
Biochemistry
Immunology
Cell Biology
Hematology
ABT-263 and Rapamycin Act Cooperatively to Kill Lymphoma Cells in Vitro and in Vivo
Molecular Cancer Therapeutics
Cancer Research
Oncology
Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation in Vivo in High-Risk Relapsed Multiple Myeloma Patients
Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer Research
Allergy
Immunology
Pharmacology
Inhibition of CHK1 Enhances Cell Death Induced by the BCL-2-Selective Inhibitor ABT-199 in Acute Myeloid Leukemia Cells
Oncotarget
Oncology
CREM Alpha Enhances IL-21 Production in T Cells in Vivo and in Vitro
Frontiers in Immunology
Allergy
Immunology
Multiple Myeloma—An in Vitro Study
British Journal of Cancer
Cancer Research
Oncology
Sorafenib Has Potent Antitumor Activity Against Multiple Myeloma in Vitro, Ex Vivo, and in Vivo in the 5T33MM Mouse Model
Cancer Research
Cancer Research
Oncology
In Vitro and in Vivo Antitumor Effects of the Recombinant Immunotoxin IL6(T23)-PE38KDEL in Multiple Myeloma
Oncology Letters
Cancer Research
Oncology
